10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q2 2015

Filing Information

Form Type	10-Q
Accession Number	`0001564590-15-003902`
Period End Date	20150331
Filing Date	20150511
Fiscal Year	2015
Fiscal Period	Q2
XBRL Instance	arwr-20150331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 85 Cash Flow Statement 75 Stockholders Equity 26

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$142.85M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	15,652.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.11M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	18,300.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$96.45M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$588.63K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	18,300.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	15,652.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.81M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$48.50K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$327.38K	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$19.56M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$21.65M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$154.80M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$120.15M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	54.66M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	59.44M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.13M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	59.44M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.87M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	54.66M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$3.24M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$25.70M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.01M	USD	Point-in-time
Investments	`HeldToMaturitySecuritiesNoncurrent`	$12.36M	USD	Point-in-time
Investments	`HeldToMaturitySecuritiesNoncurrent`	$23.09M	USD	Point-in-time
Other assets	`OtherAssetsMiscellaneousNoncurrent`	$41.41K	USD	Point-in-time
Other assets	`OtherAssetsMiscellaneousNoncurrent`	$41.41K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$162.38M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$182.82M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.94M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.58M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$2.04M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.40M	USD	Point-in-time
Due to Novartis	`AssetAcquisitionAccruedPurchasePricePayable`	$3.00M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$1.27M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$3.27M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$65.62K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$103.12K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$1.62M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$4.17M	USD	Point-in-time
Capital lease obligation	`CapitalLeaseObligationsCurrent`	$213.99K	USD	Point-in-time
Capital lease obligation	`CapitalLeaseObligationsCurrent`	$215.76K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$50.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$58.49K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$59.76K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$13.21M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$11.85M	USD	Point-in-time
Capital lease obligation, net of current portion	`CapitalLeaseObligationsNoncurrent`	$650.01K	USD	Point-in-time
Capital lease obligation, net of current portion	`CapitalLeaseObligationsNoncurrent`	$758.34K	USD	Point-in-time
Contingent consideration obligations	`BusinessCombinationContingentConsiderationLiability`	$3.97M	USD	Point-in-time
Contingent consideration obligations	`BusinessCombinationContingentConsiderationLiability`	$3.97M	USD	Point-in-time
Contingent consideration obligations	`BusinessCombinationContingentConsiderationLiability`	$1.60M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$255.21K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$350.80K	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$4.98M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$4.97M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 15,652 and 18,300 shares issued and outstanding as of March 31, 2015 and September 30, 2014, respectively	`PreferredStockValue`	$18.00	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 15,652 and 18,300 shares issued and outstanding as of March 31, 2015 and September 30, 2014, respectively	`PreferredStockValue`	$16.00	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 59,435,862 and 54,656,936 shares issued and outstanding as of March 31, 2015 and September 30, 2014, respectively	`CommonStockValue`	$147.03K	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 59,435,862 and 54,656,936 shares issued and outstanding as of March 31, 2015 and September 30, 2014, respectively	`CommonStockValue`	$151.81K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$420.70M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$391.16M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-63.97K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-224.77M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-276.03M	USD	Point-in-time
Total Arrowhead Research Corporation stockholders' equity	`StockholdersEquity`	$144.75M	USD	Point-in-time
Total Arrowhead Research Corporation stockholders' equity	`StockholdersEquity`	$166.54M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$144.20M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$165.99M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.73M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$162.38M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$182.82M	USD	Point-in-time

Income Statement 85 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`Revenues`	$87.50K	USD	2 Qtrs
REVENUE	`Revenues`	$214.50K	USD	2 Qtrs
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$5.22M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$11.64M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$29.39M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$8.35M	USD	2 Qtrs
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$10.14M	USD	2 Qtrs
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$10.14M	USD	1 Quarter
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$5.18M	USD	2 Qtrs
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$3.10M	USD	1 Quarter
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$3.54M	USD	1 Quarter
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$6.69M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.26M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$3.78M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.35M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.70M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.21M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$1.72M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$4.22M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.20M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$739.60K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$799.18K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$395.78K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$449.56K	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$29.68M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$18.31M	USD	2 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$11.26M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$54.96M	USD	2 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-18.22M	USD	2 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-54.75M	USD	2 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-29.63M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-11.21M	USD	1 Quarter
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$-148.05K	USD	2 Qtrs
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$-9.60K	USD	1 Quarter
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$-58.88K	USD	2 Qtrs
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$19.20K	USD	2 Qtrs
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$45.58K	USD	1 Quarter
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$-5.32K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$198.11K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$119.39K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$435.53K	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$159.97K	USD	2 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-2.95M	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$2.55M	USD	2 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-6.47M	USD	2 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$168.97K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$536.09K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$71.22K	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$482.90K	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$76.55K	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$3.49M	USD	2 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$-6.45M	USD	2 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$948.75K	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$-2.77M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-13.98M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-51.26M	USD	2 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-28.68M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-24.67M	USD	2 Qtrs
NET LOSS	`ProfitLoss`	$-13.98M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-51.26M	USD	2 Qtrs
NET LOSS	`ProfitLoss`	$-28.68M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-24.67M	USD	2 Qtrs
NET LOSS	`ProfitLoss`	$-58.73M	USD	Annual
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-40.18K	USD	1 Quarter
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-97.60K	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-51.26M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-24.57M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-28.68M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-13.94M	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.31	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.93	USD	2 Qtrs
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.51	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.60	USD	2 Qtrs
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	40.94M	shares	2 Qtrs
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	55.72M	shares	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	44.32M	shares	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	55.20M	shares	2 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-63.97K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-63.97K	USD	2 Qtrs
COMPREHENSIVE LOSS ATTRIBUTABLE TO ARROWHEAD	`ComprehensiveIncomeNetOfTax`	$-28.75M	USD	1 Quarter
COMPREHENSIVE LOSS ATTRIBUTABLE TO ARROWHEAD	`ComprehensiveIncomeNetOfTax`	$-13.94M	USD	1 Quarter
COMPREHENSIVE LOSS ATTRIBUTABLE TO ARROWHEAD	`ComprehensiveIncomeNetOfTax`	$-51.33M	USD	2 Qtrs
COMPREHENSIVE LOSS ATTRIBUTABLE TO ARROWHEAD	`ComprehensiveIncomeNetOfTax`	$-24.57M	USD	2 Qtrs

Cash Flow Statement 75 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-13.98M	USD	1 Quarter
Net loss	`ProfitLoss`	$-51.26M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-28.68M	USD	1 Quarter
Net loss	`ProfitLoss`	$-24.67M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-58.73M	USD	Annual
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-40.18K	USD	1 Quarter
Net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-97.60K	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-51.26M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-24.57M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-28.68M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-13.94M	USD	1 Quarter
(Gain) loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-58.88K	USD	2 Qtrs
(Gain) loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$19.20K	USD	2 Qtrs
(Gain) loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$45.58K	USD	1 Quarter
(Gain) loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-5.32K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-2.95M	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$2.55M	USD	2 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-6.47M	USD	2 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$168.97K	USD	1 Quarter
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$10.14M	USD	2 Qtrs
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$10.14M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.21M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$1.72M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$4.22M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.20M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$739.60K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$799.18K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$395.78K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$449.56K	USD	1 Quarter
Amortization of note premiums	`AmortizationOfDebtDiscountPremium`	$269.31K	USD	2 Qtrs
Amortization of note premiums	`AmortizationOfDebtDiscountPremium`	$668.36K	USD	2 Qtrs
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-40.18K	USD	1 Quarter
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-97.60K	USD	2 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$-75.00K	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$279.50K	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$611.36K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$3.22M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$206.01K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.40M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.31M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$275.37K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.44M	USD	2 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-214.33K	USD	2 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$34.42K	USD	2 Qtrs
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-40.57M	USD	2 Qtrs
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-14.72M	USD	2 Qtrs
Cash paid for acquisitions	`PaymentsToAcquireAssetsInvestingActivities`	$7.00M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$852.06K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$607.77K	USD	2 Qtrs
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$500.00	USD	2 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$46.37M	USD	2 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$5.01M	USD	2 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$12.15M	USD	2 Qtrs
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$4.30M	USD	2 Qtrs
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-41.96M	USD	2 Qtrs
Principal payments on capital leases and notes payable	`RepaymentsOfLongTermCapitalLeaseObligations`	$204.45K	USD	2 Qtrs
Principal payments on capital leases and notes payable	`RepaymentsOfLongTermCapitalLeaseObligations`	$106.55K	USD	2 Qtrs
Proceeds from issuance of common stock and preferred stock, net	`ProceedsFromIssuanceOrSaleOfEquity`	$172.64M	USD	2 Qtrs
Proceeds from the exercise of warrants and stock options	`ProceedsFromExerciseOfWarrantsAndStockOptions`	$313.62K	USD	2 Qtrs
Proceeds from the exercise of warrants and stock options	`ProceedsFromExerciseOfWarrantsAndStockOptions`	$7.98M	USD	2 Qtrs
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$180.42M	USD	2 Qtrs
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$207.06K	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-36.06M	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$123.73M	USD	2 Qtrs
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$142.85M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$19.11M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$96.45M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$142.85M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$19.11M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$96.45M	USD	Point-in-time
Interest paid	`InterestPaid`	$7.66K	USD	2 Qtrs
Interest paid	`InterestPaid`	$17.11K	USD	2 Qtrs
Common stock issued to Novartis for asset acquisition	`CommonStockIssuedForAssetAcquisition`	$25.00M	USD	2 Qtrs

Stockholders Equity 26 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$144.20M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$165.99M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.73M	USD	Point-in-time
Exercise of warrants, Amount	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$270.62K	USD	2 Qtrs
Exercise of warrants, Amount	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$10.15M	USD	Annual
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$43.13K	USD	2 Qtrs
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.73M	USD	Annual
Stock options exercised	`StockIssuedDuringPeriodSharesStockOptionsExercised`	454,863.00	shares	Annual
Stock options exercised	`StockIssuedDuringPeriodSharesStockOptionsExercised`	17,500.00	shares	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.70M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$4.22M	USD	2 Qtrs
Exercise of exchange rights, Amount	`ExchangeRightsExercisedDuringPeriodValue`	$3.07K	USD	2 Qtrs
Stock issuances, Shares	`StockIssuedDuringPeriodSharesNewIssues`	3.07M	shares	Point-in-time
Stock issuances, Shares	`StockIssuedDuringPeriodSharesNewIssues`	6.33M	shares	Point-in-time
Settlements related to derivative liability	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$5.96M	USD	Annual
Deconsolidation of Calando Pharmaceuticals, Inc.	`NoncontrollingInterestDecreaseFromDeconsolidation`	$1.30M	USD	Annual
Net loss	`ProfitLoss`	$-13.98M	USD	1 Quarter
Net loss	`ProfitLoss`	$-51.26M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-28.68M	USD	1 Quarter
Net loss	`ProfitLoss`	$-24.67M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-58.73M	USD	Annual
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$144.20M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$165.99M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.73M	USD	Point-in-time
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-63.97K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-63.97K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.